Gene Therapy Patent Suit Against Sarepta Comes To Close
Sarepta Therapeutics Inc. no longer has to face a lawsuit accusing it of infringing a University of Pennsylvania gene therapy patent licensed by clinical-stage biotechnology company Regenxbio Inc. after the parties...To view the full article, register now.
Already a subscriber? Click here to view full article